177 related articles for article (PubMed ID: 4563394)
1. [Data on changes in blood and urinary uric acid induced by a urate oxidase].
Villiaumey J; Larget-Piet B; Rotterdam M
Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):138-40. PubMed ID: 4563394
[No Abstract] [Full Text] [Related]
2. [Clinical trial of urate oxidase].
Asch L
Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):129-36. PubMed ID: 4563393
[No Abstract] [Full Text] [Related]
3. [Clinical experience with a new uricolytic agent].
Alessandri C; Violi F; Bonavita MS
Recenti Prog Med; 1986 Mar; 77(3):147-8. PubMed ID: 3715181
[No Abstract] [Full Text] [Related]
4. Enzymatic uricolysis: a study of the effect of a fungal urate-oxydase.
Brogard JM; Coumaros D; Franckhauser J; Stahl A; Stahl J
Rev Eur Etud Clin Biol; 1972 Nov; 17(9):890-5. PubMed ID: 4631795
[No Abstract] [Full Text] [Related]
5. [New trend in gout treatment. Clinical and biological study of urate oxidase].
Mizon JP; Plaquet R; Gentit F; Quiret JC
Lille Med; 1971 Nov; 16(9):1332-45. PubMed ID: 4945000
[No Abstract] [Full Text] [Related]
6. [Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias].
Potaux L; Aparicio M; Maurel C; Ruedas ME; Martin-Dupont Cl
Nouv Presse Med; 1975 Apr; 4(15):1109-12. PubMed ID: 1094413
[TBL] [Abstract][Full Text] [Related]
7. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
Royer R; Vindel J; Lamarche M; Kissel P
Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
[No Abstract] [Full Text] [Related]
8. [Experimentation with urate oxidase].
Louyot P; Laurent-Montet Y; Roland J; Pourel G
J Belge Rhumatol Med Phys; 1971; 26(4):169-78. PubMed ID: 5147001
[No Abstract] [Full Text] [Related]
9. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
Rozenberg S; Roche B; Dorent R; Koeger AC; Borget C; Wrona N; Bourgeois P
Rev Rhum Engl Ed; 1995 May; 62(5):392-4. PubMed ID: 7655872
[TBL] [Abstract][Full Text] [Related]
10. Pegloticase (krystexxa) for treatment of refractory gout.
Med Lett Drugs Ther; 2011 Feb; 53(1357):9-10. PubMed ID: 21304442
[No Abstract] [Full Text] [Related]
11. [Uric acid and its metabolism].
Kissel P; Royer R
Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
[No Abstract] [Full Text] [Related]
12. [Use of enzymatic uricolysis in the treatment of hyperuricemia of renal origin].
Brogard JM; Frankhauser J; Stahl A
Schweiz Med Wochenschr; 1973 Mar; 103(11):404-10. PubMed ID: 4691800
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
Sundy JS; Ganson NJ; Kelly SJ; Scarlett EL; Rehrig CD; Huang W; Hershfield MS
Arthritis Rheum; 2007 Mar; 56(3):1021-8. PubMed ID: 17328081
[TBL] [Abstract][Full Text] [Related]
14. [Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)].
Vigo P; Ortolani S; Soldati L; Girardello R; Fleischmann L; Polli EE
Haematologica; 1981 Oct; 66(5):656-66. PubMed ID: 6796473
[No Abstract] [Full Text] [Related]
15. [Comparative study of uric acid renal elimination in the gout patients and normal patients in spontaneous or experimentally increased or decreased uricemia].
Prost A; Fontenaille C; Guiheneuc P; Héron B; Lucas J
Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):33-9. PubMed ID: 4820524
[No Abstract] [Full Text] [Related]
16. Resolution of gouty tophi after twelve weeks of pegloticase treatment.
Baraf HS; Matsumoto AK; Maroli AN; Waltrip RW
Arthritis Rheum; 2008 Nov; 58(11):3632-4. PubMed ID: 18975338
[No Abstract] [Full Text] [Related]
17. Renal excretion of urate in normal and gouty subjects at high, normal and low plasma urate levels.
Fontenaille C; Guiheneuc P; Heron B; Prost A; Lucas J
Biomedicine; 1974 Sep; 21(9):382-5. PubMed ID: 4457158
[No Abstract] [Full Text] [Related]
18. [Gout. Clinical aspects, pathogenesis, current treatment].
Galmiche P
Cah Med; 1971 Apr; 12(6):403-13. PubMed ID: 4934051
[No Abstract] [Full Text] [Related]
19. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
Yue CS; Huang W; Alton M; Maroli AN; Waltrip RW; Wright D; Marco MD
J Clin Pharmacol; 2008 Jun; 48(6):708-18. PubMed ID: 18420531
[TBL] [Abstract][Full Text] [Related]
20. Modification of uricaemia and the excretion of uric acid nitrogen by an enzyme of fungal origin.
Kissel P; Lamarche M; Royer R
Nature; 1968 Jan; 217(5123):72-4. PubMed ID: 5635636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
